You will typically receive an uncomfortable laugh when you ask a QA manager how much of their week is spent on actual testing as opposed to finding paperwork. That gap is the real story behind validation in pharma today. Protocols get signed in one system, lab results live in another, and manufacturing records sit somewhere else entirely. Pulling it all together for an audit becomes its own project.

Regulatory validation doesn’t have to work this way anymore. Pharma companies are starting to link data across QMS, LIMS, MES, and ERP platforms so records stay connected instead of scattered. Add in AI in pharma tools that handle the searching and cross-checking, and computer system validation stops being a once-a-year scramble.

Approval decisions still rest with people — that hasn’t changed under GAMP 5 or ICH standards. What’s different is how much less digging it takes to get there.